GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,074,000 | +0.1% | 257,582 | +1.6% | 2.62% | +20.9% |
| Q1 2022 | $11,060,000 | +8.8% | 253,543 | +9.2% | 2.17% | -5.2% |
| Q4 2021 | $10,165,000 | +7.7% | 232,227 | +0.9% | 2.29% | -7.1% |
| Q3 2021 | $9,436,000 | +12.5% | 230,229 | +9.3% | 2.46% | +20.6% |
| Q2 2021 | $8,385,000 | +14.2% | 210,570 | +3.4% | 2.04% | +8.4% |
| Q1 2021 | $7,341,000 | +1.1% | 203,649 | +4.6% | 1.88% | +7.0% |
| Q4 2020 | $7,264,000 | -0.9% | 194,638 | +0.7% | 1.76% | -5.1% |
| Q3 2020 | $7,329,000 | -99.9% | 193,320 | -0.4% | 1.86% | -16.4% |
| Q2 2020 | $7,964,716,000 | +96045.8% | 194,003 | -1.7% | 2.22% | -19.0% |
| Q1 2020 | $8,284,000 | -49.4% | 197,337 | -43.3% | 2.74% | -53.6% |
| Q4 2019 | $16,364,000 | – | 348,239 | – | 5.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |